Showing results (921-930 of 1,096) with videos related to
Sort By:
Pageof 110
American Journal of Hematology|August 18, 2018
P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse-free survivalRita Assi, Hatice D Gur, Sanam Loghavi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2026
Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance ProfileLuise Rogg, Sebastian A Nuñez, María Verónica Mingrone, et al.BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.Antimicrobial Agents and Chemotherapy|January 3, 2022
Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or RilpivirineJerry L Jeffrey, Marty St Clair, Ping Wang, et al.Archives of Pathology & Laboratory Medicine|January 25, 2021
Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation SequencingNisha S Ramani, Keyur P Patel, Mark J Routbort, et al.Histopathology|June 30, 2015
Crystal-storing histiocytosis: a clinicopathological study of 13 casesRashmi Kanagal-Shamanna, Zijun Y Xu-Monette, Roberto N Miranda, et al.Human Pathology|August 8, 2018
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruptionSofia Garces, Joseph D Khoury, Rashmi Kanagal-Shamanna, et al.Leukemia Research|January 10, 2015
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.Leukemia & Lymphoma|March 16, 2013
Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphomaBouthaina S Dabaja, Jack Phan, Osama Mawlawi, et al.Clinical Lymphoma, Myeloma & Leukemia|February 20, 2014
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationYi Zhou, Rebecca Slack, Jeffrey L Jorgensen, et al.Pageof 110